Request to Join
has invited you to join this group
has invited you to join this group
Internal Medicine second year resident at Duke University Medical Center.
Fellow at Division of Gastroenterology, Hepatology & Nutrition, UT Health Science Center at San Antonio
Resident Physician at Sinai Hospital of Baltimore
Resident Physician at Lahey Hospital & Medical Center
GI Fellowship Program Program Director at Allegheny General Hospital
Assistant Professor of Medicine, Division of Gastroenterology and Nutrition at UT Health Science Center San Antonio
Primary Care Provider at San Francisco Department of Public Health’s Tom Waddell Urban Health Clinic
Assistant Professor Medicine in the Division of Infectious Diseases at Rutgers New Jersey Medical School
Director of Hepatobiliary Cancer at Texas Liver Institute, Department of Hepatology, University of Texas Health Science Center San Antonio
Assistant Clinical Professor of Medicine, Infectious Diseases at The University of California, Los Angeles
Assistant Clinical Professor at David Geffen School of Medicine at UCLA
Program Director, Sinai Hospital of Baltimore Internal Medicine Residency Program; Assistant Director, Division of Infectious Diseases at Sinai Hospital of Baltimore
Chief and Program Director of the Division of Infectious Diseases at St. John Hospital and Medical Center
Associate Professor of Medicine and Surgery at Division of Gastroenterology & Hepatology at Northwestern University Feinberg School of Medicine
Chief Hepatologist at Baylor Scott & White, TempleTX
Assistant Professor of Medicine at Emory University School of Medicine
Assistant Professor of Pediatrics, Hepatology
GI Attending Physician at Union Hospital of Cecil County
MD/MBA Candidate at Tufts University School of Medicine
MD Candidate at Oakland University William Beaumont School of Medicine
Hepatitis C treatment has been changing at a pace almost too rapid for the average physician to keep up with. Until recently, HCV treatment required weekly interferon injections plus oral ribavirin for up to a year and was effective in only about half of patients with genotype 1. During the past 2 years, however, several highly effective, fast-acting, all-oral, interferon-free regimens have been approved, raising the possibility of eradicating HCV in many patients. When should these treatments be offered? Which regimens are best for which patients? And what about the exorbitant cost of these new regimens?
In this discussion, we'll tackle these and other challenging aspects of hepatitis C treatment in the clinic. We'll kick off the discussion with a case from NEJM Knowledge+ and then open up the floor for others to present their cases.
NEJM Knowledge+ is the most efficient, engaging, and effective way for physicians to learn, improve the quality of their practice, and prepare for board exams.
Internal Medicine second year resident at Duke University Medical Center.
Fellow at Division of Gastroenterology, Hepatology & Nutrition, UT Health Science Center at San Antonio
Resident Physician at Sinai Hospital of Baltimore
Resident Physician at Lahey Hospital & Medical Center
GI Fellowship Program Program Director at Allegheny General Hospital
Assistant Professor of Medicine, Division of Gastroenterology and Nutrition at UT Health Science Center San Antonio
Primary Care Provider at San Francisco Department of Public Health’s Tom Waddell Urban Health Clinic
Assistant Professor Medicine in the Division of Infectious Diseases at Rutgers New Jersey Medical School
Director of Hepatobiliary Cancer at Texas Liver Institute, Department of Hepatology, University of Texas Health Science Center San Antonio
Assistant Clinical Professor of Medicine, Infectious Diseases at The University of California, Los Angeles
Assistant Clinical Professor at David Geffen School of Medicine at UCLA
Program Director, Sinai Hospital of Baltimore Internal Medicine Residency Program; Assistant Director, Division of Infectious Diseases at Sinai Hospital of Baltimore
Chief and Program Director of the Division of Infectious Diseases at St. John Hospital and Medical Center
Associate Professor of Medicine and Surgery at Division of Gastroenterology & Hepatology at Northwestern University Feinberg School of Medicine
Chief Hepatologist at Baylor Scott & White, TempleTX
Assistant Professor of Medicine at Emory University School of Medicine
Assistant Professor of Pediatrics, Hepatology
GI Attending Physician at Union Hospital of Cecil County
MD/MBA Candidate at Tufts University School of Medicine
MD Candidate at Oakland University William Beaumont School of Medicine